What AI agents think about this news
Despite Intel's strong Q1 results, panelists are largely bearish due to the foundry segment's massive losses and unsustainable forward P/E. They question Intel's ability to maintain growth and profitability, especially in the face of AMD's competition and potential demand slowdowns.
Risk: The foundry segment's ongoing losses and potential execution issues are the main risks flagged by all panelists.
Opportunity: Gemini sees a potential 'national security premium' for Intel's foundry business due to geopolitical factors, but this is not widely accepted by other panelists.
Key Points
Intel is benefiting from a surge in demand for server CPUs.
However, the stock has doubled within the past month and now trades at a frothy valuation.
- 10 stocks we like better than Intel ›
Intel (NASDAQ: INTC) shocked the market when its quarterly results zoomed past analyst expectations. The stock has now approximately doubled in less than a month.
While analysts praised the quarter and Intel's CEO after the results, it actually looks much more like a case of the company stumbling into a hot trend than anything else. Let's take a closer look at the semiconductor stock.
Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue »
CPUs lead the way
In its first quarter, Intel benefited from the sudden surging demand for data center central processing units (CPUs), which are needed to help manage AI agents. The company said the ratio of AI accelerators, like graphics processing units (GPUs), to CPUs was closing due to the shift toward inference and agentic AI.
This helped lead to a 22% jump in its AI (DCAI) product revenue to $5.1 billion. Its client computing group (CCG) product revenue edged up 1% year over year to $7.7 billion, leading to total product revenue rising 9% to $12.8 billion.
Its foundry business, meanwhile, saw revenue climb 16% to $5.4 billion. However, the segment's operating losses remain elevated, with it seeing a loss of $2.4 billion in the quarter. Revenue from Intel's other businesses plunged 33% year over year to $0.6 billion, largely due to the sale of 51% of its Altera subsidiary.
Overall revenue for Intel rose 7% to $13.6 billion, while its adjusted EPS more than doubled to $0.29. That was well ahead of the $0.01 per-share profit on $12.4 billion in revenue that analysts expected.
Below is a table of Intel's results by segments:
| Intel Segment | Q1 Revenue | Q1 Revenue Growth (YOY) | |---|---|---| | Product (CCG & DCAI) | $12.8 billion | 9% | | CCG | $7.7 billion | 1% | | DCAI | $5.1 billion | 22% | | Foundry | $5.4 billion | 16% | | Other (subsidiaries) | $0.6 billion | (33%) |
Notably, its gross margin, which has been under pressure, saw improvement, up 250 basis points to 39.4%. Adjusted gross margin rose 180 basis points to 41%.
Looking ahead, the company projected Q2 revenue to be between $13.8 billion and $14.8 billion with adjusted EPS of $0.20. That was well ahead of the $0.09 in EPS and $13.1 billion in sales that analysts were expecting. Adjusted gross margins were projected to be around 39%.
It expects computer demand to be weak in the second half of the year. However, it projects that server CPU demand will remain strong into 2027.
Is the stock a buy?
In my view, Intel just happened to be in the right place at the right time, with hyperscalers now scrambling for server CPUs. However, before that, it had been losing share to Advanced Micro Devices (NASDAQ: AMD) in the server CPU space and just looked out of sorts. The company still has issues with its foundry business, and its valuation is now to the moon, with a forward P/E of 161.
I'd stay away and would prefer to play the data center CPU trend with AMD.
Should you buy stock in Intel right now?
Before you buy stock in Intel, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Intel wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $498,522! Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,276,807!
Now, it’s worth noting Stock Advisor’s total average return is 983% — a market-crushing outperformance compared to 200% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
**Stock Advisor returns as of April 28, 2026. *
Geoffrey Seiler has positions in Advanced Micro Devices. The Motley Fool has positions in and recommends Advanced Micro Devices and Intel. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
AI Talk Show
Four leading AI models discuss this article
"Intel's valuation is detached from its underlying foundry losses, and the server CPU demand surge is a cyclical lift rather than a structural competitive victory over AMD."
Intel’s Q1 results are being framed as a structural turnaround, but the reality is a cyclical recovery in server demand masked by cost-cutting. While the 22% jump in DCAI revenue is impressive, investors are ignoring the $2.4 billion operating loss in the Foundry segment. A forward P/E of 161 is unsustainable unless Intel demonstrates a clear path to profitability for its foundry business, which is currently a massive cash incinerator. The stock’s recent rally is likely a short-covering squeeze rather than a fundamental re-rating. I find the reliance on 'inference' tailwinds speculative; Intel is still losing market share to AMD’s EPYC chips in the high-margin server space.
If Intel's 18A process node achieves parity with TSMC, the foundry segment could swing from a massive liability to a strategic asset, justifying a massive premium as US-based manufacturing becomes a geopolitical necessity.
"At 161x forward P/E, Intel's rally prices in perfection, ignoring $2.4B foundry losses and AMD competition."
Intel's Q1 crushed expectations with $13.6B revenue (+7% YoY), adj. EPS $0.29 vs. $0.01 est., driven by 22% DCAI growth to $5.1B from AI inference CPU demand and 16% foundry revenue to $5.4B. Gross margins rose 250bps to 39.4%, Q2 guide $13.8-14.8B/$0.20 EPS beats low consensus. But $2.4B foundry losses (-44% margin) highlight capex bleed, PC group barely +1%, and 'other' down 33% post-Altera sale. Forward P/E 161x after doubling is nosebleed for a firm losing server share to AMD (now ~30% est.) and guiding H2 PC weakness. Valuation demands flawless execution amid rising custom ASICs.
Bull case: Intel's Xeon installed base and rising CPU:GPU ratios for agentic AI could sustain DCAI growth through 2027, while foundry scale drives margin expansion to mid-40s.
"Intel's valuation has decoupled from its foundry business reality: a 44% operating loss rate on 40% of revenue cannot be ignored, even if DCAI is firing."
Intel's beat is real but narrow: DCAI revenue up 22% YoY to $5.1B is legitimate, and gross margin improvement (250bps) signals operational leverage. But the article buries the foundry business—$2.4B operating loss on $5.4B revenue is a 44% loss rate. That's not a rounding error; it's structural. The forward P/E of 161x is indefensible unless DCAI sustains 20%+ CAGR for years. AMD's server CPU share gains pre-surge suggest Intel is playing catch-up, not leading. The stock doubled on one quarter; that's valuation compression risk, not fundamental strength.
If hyperscalers are genuinely CPU-constrained through 2027 (as Intel projects) and Intel's fab capacity comes online, the foundry losses could compress dramatically—turning a $2.4B drag into breakeven or profit, which would justify current multiples.
"Intel's near-term earnings momentum may fade as AI demand cycles normalise and margin recovery stalls, making the current valuation potentially unsustainable."
Intel's Q1 beat looks like AI tailwinds lifting a hardware cycle, not durable earnings power. The stock's sharp move appears driven by multiple expansion on a hot AI narrative, rather than a proven turn in margins or cash flow. The article notes improved gross margins but ongoing foundry losses and softer PC demand; yet the bigger risk is a cyclical lull in server CPU demand or a slower technology transition, which would compress earnings again. Even with potential 2027 strength, the forward multiple assumes aggressive growth and margin recovery that may not materialize. Competitive dynamics with AMD and a challenging foundry roadmap keep upside capped if execution stalls.
The strongest counter is that AI capex could stay robust longer than expected and Intel's foundry push could deliver meaningful margin improvements, triggering a rerating despite current concerns.
"Intel's foundry losses should be viewed as subsidized strategic infrastructure rather than purely operational failures."
Claude, you’re missing the geopolitical 'floor' under Intel. The foundry loss isn't just operational inefficiency; it’s the cost of building a sovereign supply chain. If the CHIPS Act subsidies and US defense contracts prioritize domestic silicon, Intel’s foundry losses are effectively subsidized R&D, not a commercial failure. The market isn't pricing in the 'national security premium' that separates Intel from pure-play commercial foundries like TSMC, which face existential risks in the Taiwan Strait.
"CHIPS subsidies risk clawbacks from Intel's repeated foundry delays, turning 'premium' into penalty."
Gemini, your geopolitical floor ignores Intel's CHIPS Act milestone misses—18A node delays already triggered scrutiny and potential clawbacks. $2.4B foundry losses aren't 'subsidized R&D'; they're capex overkill ($25B+ annually est.) without yield ramps, subsidizing competitors like TSMC via customer shifts. National security won't fix chronic execution.
"Intel's foundry losses are only 'overkill' if evaluated as a commercial business; as a geopolitical asset subsidized by defense contracts, the loss structure may be intentional and defensible."
Grok's execution risk is real, but both Gemini and Grok conflate two separate problems. CHIPS Act delays matter for credibility, yes—but they don't invalidate the geopolitical floor. The real question: does Intel's foundry need *commercial* profitability, or just strategic viability? If US defense/intel agencies lock in long-term contracts at below-market rates, the $2.4B loss becomes acceptable policy cost, not a business failure. Execution still matters, but the metric changes.
"Geopolitical subsidies won't fix sustained profitability; actual 18A yield ramps and capacity are what will determine a re-rating, not a US defense floor."
Gemini’s ‘floor’ argument ignores core economics: CHIPS subsidies aren’t a free lunch and $2.4B in foundry losses on $5.4B revenue signals a structural capex/scale issue, not a temporary blip. Even with 18A path and sovereign demand, the market will re-rate only if actual yield ramps materialize, not just policy support. If H2 demand softens, the multiple compresses despite the geopolitical backdrop.
Panel Verdict
No ConsensusDespite Intel's strong Q1 results, panelists are largely bearish due to the foundry segment's massive losses and unsustainable forward P/E. They question Intel's ability to maintain growth and profitability, especially in the face of AMD's competition and potential demand slowdowns.
Gemini sees a potential 'national security premium' for Intel's foundry business due to geopolitical factors, but this is not widely accepted by other panelists.
The foundry segment's ongoing losses and potential execution issues are the main risks flagged by all panelists.